Please login to the form below

Not currently logged in
Email:
Password:

Ben Fisher to lead Hive's med ed agency

He joins Pollen from Ogilvy Healthworld

Ben Fisher The Hive Group has appointed Ben Fisher as head of Pollen, its London-based medical education agency.

Fisher joins Pollen from Ogilvy Healthworld, where he spent four years, latterly as group director, prior to which he was an account director at Porter Novelli.

Founded in 2011, Pollen works with healthcare companies to deliver strategic communication campaigns, focuses on applying the principles of storytelling to enable accurate scientific exchange.

“Pollen is built on a belief in scientific storytelling,” said Fisher. “It is the promise of connecting the science to the real lives of our target audience. It is an alternative, exciting approach and I'm delighted to join the team.”

“Pollen is unique - and requires a uniquely diverse group of talent to connect science with the real world” said Jas Hummel, founding director of the Hive Group.

“We believe Ben is the right person to lead Pollen and bring it to a greater number of clients.”

25th March 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....
Six factors that drive a multiple sclerosis patient's choice of disease-modifying therapy
MS advocate Trishna Bharadia explains the numerous factors that lead patients to choose a disease-modifying therapy, including the important considerations healthcare professionals and pharma often forget....

Infographics